Pediatrix Medical Group, Inc. Stockholders Equity

• Pediatrix Medical Group, Inc. showed an increase of +13.2% in Stockholders Equity from 2024 to 2025.
• This data is from Pediatrix Medical Group, Inc.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
• XBRL data for this metric is available from 2007 to 2025 (19 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q3 2010: $1.37 billion | Q1 2011: $1.51 billion | Q2 2011: $1.59 billion | Q3 2011: $1.66 billion | Q1 2012: $1.80 billion | Q2 2012: $1.87 billion | Q3 2012: $1.95 billion | Q1 2013: $2.11 billion | Q2 2013: $2.19 billion | Q3 2013: $2.23 billion | Q1 2014: $2.31 billion | Q2 2014: $2.40 billion | Q3 2014: $2.50 billion | Q1 2015: $2.11 billion | Q2 2015: $2.22 billion | Q3 2015: $2.33 billion | Q1 2016: $2.46 billion | Q2 2016: $2.56 billion | Q3 2016: $2.67 billion | Q1 2017: $2.76 billion | Q2 2017: $2.84 billion | Q3 2017: $2.92 billion | Q1 2018: $3.14 billion | Q2 2018: $3.19 billion | Q3 2018: $3.02 billion | Q1 2019: $2.78 billion | Q2 2019: $2.73 billion | Q3 2019: $1.48 billion | Q1 2020: $1.49 billion | Q2 2020: $826.57 million | Q3 2020: $804.76 million | Q1 2021: $766.76 million | Q2 2021: $808.91 million | Q3 2021: $845.47 million | Q1 2022: $877.08 million | Q2 2022: $845.43 million | Q3 2022: $858.67 million | Q1 2023: $909.77 million | Q2 2023: $942.38 million | Q3 2023: $967.99 million | Q1 2024: $856.20 million | Q2 2024: $706.46 million | Q3 2024: $732.49 million | Q1 2025: $789.19 million | Q2 2025: $833.75 million | Q3 2025: $890.67 million.
• Over the full 19 years of available data (2007 to 2025), Pediatrix Medical Group, Inc.'s Stockholders Equity has declined by 9.7%.
• Historical annual values: Fiscal year 2025: $865.85 million | Fiscal year 2024: $764.94 million | Fiscal year 2023: $849.06 million | Fiscal year 2022: $891.63 million | Fiscal year 2021: $896.49 million | Fiscal year 2020: $747.49 million | Fiscal year 2019: $1.50 billion | Fiscal year 2018: $3.09 billion | Fiscal year 2017: $3.07 billion | Fiscal year 2016: $2.76 billion | Fiscal year 2015: $2.44 billion | Fiscal year 2014: $2.26 billion | Fiscal year 2013: $2.34 billion | Fiscal year 2012: $2.04 billion | Fiscal year 2011: $1.73 billion | Fiscal year 2010: $1.45 billion | Fiscal year 2009: $1.19 billion | Fiscal year 2008: $965.14 million | Fiscal year 2007: $959.05 million.
• Data sourced from SEC EDGAR public filings as of August 5, 2026.

Last verified: August 5, 2026